AC676
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AC676, covering 2025-10-02 to 2025-10-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies [Phase 1]